Dr. Dattatreyudu Nori | |
|---|---|
 Dattatreyudu Nori (left) receiving the Padma Shri award from the President of India Shri Pranab Mukherjee (right). | |
| Born | 1947 |
| Education | M.D. |
| Known for | Radiation oncology |
| Medical career | |
| Institutions | Memorial Sloan Kettering Cancer Center |
Dr. Dattatreyudu Nori is a noted Indo-American radiation oncologist. [1] [2] He was once named one of the top doctors in America for the treatment of cancers in women by the women's magazine Ladies' Home Journal .
Dattatreyudu Nori was born in a Telugu family in Mantada village, Krishna district of Andhra Pradesh, India. He did his schooling at Machilipatnam. He obtained his medical degree from Kurnool Medical College and Post graduate degree from Osmania Medical College.
Dr. Nori is a Professor and Executive Vice Chairman of the Radiation Oncology Department at The NewYork–Presbyterian Hospital / Weill Cornell Medical College in New York City. In addition, Dr. Nori is the Chairman of Radiation Oncology Unit at the New York Hospital Medical Center of Queens.
Dr. Nori is one of the world's leading authorities in the subspecialty of brachytherapy. In 1979, he was the first physician in the United States to work with a computerized brachytherapy treatment system and develop new techniques through clinical research. He was instrumental in the development and successful application of brachytherapy; the implantation of radioactive seeds to combat cancer.[ citation needed ]
He developed and popularized the transperineal brachytherapy technique, a non-surgical approach for seed implantation, which improved the quality of life for men with prostate cancer. Dr. Nori has been given the 'honor of Tribute to Life' by the American Cancer Society (ACS). The honor was bestowed by Don Distacio, regional director of the ACS in recognition of his contributions to cancer research, patient care and treatment, and education for the past one and a half decades.[ citation needed ]
He was awarded Padma Shri, the fourth-highest civilian award of India, in 2015 for his contributions in the field of medicine. [3]
A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors. In some countries, radiotherapy and chemotherapy are controlled by a single oncologist who is a "clinical oncologist". Radiation oncologists work closely with other physicians such as surgical oncologists, interventional radiologists, internal medicine subspecialists, and medical oncologists, as well as medical physicists and technicians as part of the multi-disciplinary cancer team. Radiation oncologists undergo four years of oncology-specific training whereas oncologists who deliver chemotherapy have two years of additional training in cancer care during fellowship after internal medicine residency in the United States.
Brachytherapy is a form of radiation therapy where a sealed radiation source is placed inside or next to the area requiring treatment. Brachy is Greek for short. Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, esophageal and skin cancer and can also be used to treat tumours in many other body sites. Treatment results have demonstrated that the cancer-cure rates of brachytherapy are either comparable to surgery and external beam radiotherapy (EBRT) or are improved when used in combination with these techniques. Brachytherapy can be used alone or in combination with other therapies such as surgery, EBRT and chemotherapy.
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 52 National Cancer Institute–designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.
The Joan & Sanford I. Weill Medical College of Cornell University is Cornell University's biomedical research unit and medical school in New York City. It is affiliated with NewYork-Presbyterian Hospital, Weill Cornell Medical Center, Hospital for Special Surgery, Memorial Sloan Kettering Cancer Center, and Rockefeller University, all of which are located on or near York Avenue and Sutton Place.
Roger Granet is an American psychiatrist and the author and editor of several books explaining mental disorders and diseases. Dr. Granet specializes in psycho-oncology, which deals with the psychological reactions of cancer patients. The field is considered an integral part of quality cancer treatment.
Brachytherapy is a type of radiotherapy, or radiation treatment, offered to certain cancer patients. There are two types of brachytherapy – high dose-rate (HDR) and low dose-rate (LDR). LDR brachytherapy is the one most commonly used to treat prostate cancer. It may be referred to as 'seed implantation' or it may be called 'pinhole surgery'.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist, oncologist, and principal investigator. Before moving to the Icahn School of Medicine in 2013, he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy, treating patients with prostate, urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon, and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically, he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit; he is on such lists as America's Top Doctors, New York Magazine's Best Doctors, and Who's Who in the World. In 2012, he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology, most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
Paul T. Finger, MD, FACS, is an ophthalmologist in New York, New York, specializing in ocular oncology. Finger is a Clinical Professor of Ophthalmology at the New York University School of Medicine in New York City, New York. He is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital and NYU School of Medicine. He is Chair of the Ophthalmic Oncology Task Force for the American Joint Committee on Cancer (AJCC), wrote the eye cancer staging systems section for the Union International for Cancer Control (UICC). As Chair, he brought together an OOTF to develop consensus eye plaque radiation guidelines for The American Brachytherapy Society - American Association of Physicists in Medicine. Dr. Finger was the first the only ophthalmologist asked to serve on the 2012 American Association of Physicists in Medicine’s Task Group-129 that produced both dosimetry and quality assurance standards for plaque brachytherapy. As of 2021, Dr. Finger has authored over 335 peer-review scientific articles, 2 books, 54 book chapters and 2 web sites.
Ketayun Ardeshir Dinshaw FRCR was a prominent personality in the field of Indian medicine and played a significant role in the evolution of modern cancer care in India, and the development of effective radiation therapy. In 2001, the President of India conferred on her the Padma Shri. A prominent news channel has described her as: “The ultimate hope and the last possible post to cling onto for the cancer-struck in India”. Over a thirty-year period, Dinshaw revolutionised cancer medicine in India, refining multi-modal treatments as the exception rather than the rule.
Simon N. Powell is a British cancer researcher and radiation oncologist residing in New York City.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.
Docrates Cancer Center is the first and currently the only private hospital in the Nordic countries that comprehensively specialises in cancer treatment. It operates in Helsinki, Finland. It characterises its operations as those complementing the public sector. Docrates Oy was established in 2006 and the hospital started its operations at the premises of Eira Hospital in autumn 2007. It moved to its own premises in Jätkäsaari, Helsinki, in 2009, where it has hospital rights. There is a ward and Health and Recovery Center located at Docrates Cancer Center. Among other things, diagnostics, pharmacotherapy, radiation therapy and isotopic treatments are carried out at the hospital. Cancer surgeries are performed in partner hospitals. Docrates also participates in clinical trials and the testing and development of new treatments.
Arthur L. Jenkins III is an American fellowship-trained neurosurgeon, co-director of the Neurosurgical Spine Program, and Director of Spinal Oncology and Minimally Invasive Spinal Surgery (MIS) Program at the Mount Sinai Hospital, New York. Additionally, he is an associate professor of Neurosurgery and of Orthopedic Surgery at the Mount Sinai School of Medicine. Dr. Jenkins has multiple patents and patent applications for spine-related implants and support systems, and is developing new minimally invasive treatments for patients with cancer that has spread to the spine. He is an innovator in the treatment of acute spinal cord injury as well as degenerative and congenital anomalies of the spine, taking a minimally invasive or minimal-impact approach where possible. He is board certified in Neurological Surgery and is licensed in New York and Connecticut.
Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.
Dr. Jitendra Kumar Singh is an Indian oncologist, the ex director of Mahavir Cancer Institute & Research Centre and the president of Cancer Care India, the apex body for cancer support organisations in India. He was honoured by the Government of India, in 2012, with the fourth highest Indian civilian award of Padma Shri.
Kadiyala Ramachandra (1919-2007) was an Indian medical doctor, poet, a former superintendent of the Government General Hospital, Chennai and a former head of the department of medicine at Madras Medical College. His efforts were reported behind the establishment of the Department of Oncology & Cancer Chemotherapy and the Rheumatic Care Unit at the General Hospital. He was a recipient of the fourth highest Indian civilian award of Padma Shri in 1974.
Mohan Chandra Pant (1956–2015) was an Indian radiation oncologist, institution builder and the founder vice chancellor of the H. N. B. Uttarakhand Medical Education University, Dehradun. He served as the Director of Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, and was the Dean and head of the Radiotherapy Department at the King George's Medical University at the time of his death. He received the Dr. B. C. Roy Award, the highest Indian award in the medical category, from the Medical Council of India in 2005. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2008, for his contributions to medicine.
Chitranjan Singh Ranawat is an American orthopedic surgeon of Indian origin.
Bruce B. Lerman is a cardiologist. He is the Hilda Altschul Master Professor of Medicine at Weill Cornell Medical College, and was chief of the Division of Cardiology and director of the Cardiac Electrophysiology Laboratory at Weill Cornell Medicine and the New York Presbyterian Hospital.